Evaluation of the peripheral dose and the conformity index for three stereotactic radiotherapy techniques: Arcs, noncoplanar fixed fields and intensity modulation by Ammar, Hany et al.
International Journal of Cancer Therapy and Oncology
www.ijcto.org
Corresponding author: Hany Ammar; Department of Radiotherapy, Children’s Cancer Hospital, Cairo, Egypt.
Cite this article as: Ammar H, Eldebawy E, Maarouf E, Khalil W, Zaghloul MS. Evaluation of the peripheral dose and the conformity index for three stereo-
tactic radiotherapy techniques: Arcs, noncoplanar fixed fields and intensity modulation. Int J Cancer Ther Oncol 2014; 2(4):02042.
DOI: 10.14319/ijcto.0204.2
Evaluation of the peripheral dose and the conformity index for three
stereotactic radiotherapy techniques: Arcs, noncoplanar fixed fields
and intensity modulation
Hany Ammar1, Eman Eldebawy1,2, Ehab Maarouf1,2, Wafaa Khalil3, MS Zaghloul1,2
1Department of Radiotherapy, Children's Cancer Hospital Egypt
2Department of Radiotherapy and Nuclear Medicine, National Cancer Institute, Cairo University
3Department of Biophysics, Faculty of Science, Cairo University
Received April 28, 2014; Revised July 03, 2014; Accepted July 04, 2014; Published Online August 23, 2014
Original Article
Abstract
Purpose: The main aim of this work is to compare the conformity index and the peripheral doses absorbed during stereotactic
treatment of a brain lesion delivered using three stereotactic techniques; Arcs, noncoplanar fixed conformal fields (3DCRT) and
intensity modulation (IMRT). Methods: Ten patients with brain lesions who were previously treated with Stereotaxy radiosur-
gery (SRS) using the cones (Arcs technique), were re-planned both non-coplanar 3D Conformal fixed fields (3DCRT) and
non-coplanar intensity modulated radiotherapy fixed fields (IMRT) with the same arrangement and orientation of the fields as
the Arcs technique. To facilitate direct comparison between the competing techniques, the primary planning object was to cov-
er 95% of the volume of PTV by 95% of the prescribed dose (1200 cGy). Results: The IMRT technique shows the highest dose
conformity, Arcs technique is the next homogeneity followed by 3DCRT. The differences were statistically significant among
the three different techniques (P < 0.01) for PITV (defined as the ratio of the prescription isodose volume (PI) and Target Vol-
ume (TV)) and Conformal Number (CN). The mean integral dose using the 3 different techniques for all studied patients were:
2.44 ± 0.36J, 2.31 ± 0.37J and 2.6 ± 0.37J in the Arcs, IMRT and 3DCRT techniques respectively, the differences were not statis-
tically significant (p = 0.326). The results show that Arcs technique has the lowest volume of the body that received 2 Gy, IMRT
is the next followed by 3DCRT and IMRT technique has the lowest volume of the body that received 5 Gy, Arcs technique is
the next followed by 3DCRT. The differences were not statistically significant p = 0.126 for V2 and p = 0.118 for V5, but these
differences might be clinically significant that need more clinical discussion and investigation. IMRT plan delivery time almost
has two folded more than the two others techniques, and the arc the technique has the lowest estimated time compared to both
IMRT and Conformal techniques. The differences were statistically significant (P < 0.01). Conclusion: The conformity index,
dose homogeneity and the outfield dose are important aspects of plan quality, although they do not always receive clinically
attention. Our results have been showed that the superiority of the IMRT in conformity, dose homogeneity and the lowest
volume that received 5 Gy, Arcs technique has the superiority in lower treatment delivery time than IMRT and the lowest
volume that received 2 Gy. The 3DCRT don't present a significant advantage among the competing techniques. Oncologist
should be alert of the possibility of significantly increasing the secondary cancer risk particularly for pediatric patients, because
children are more susceptible to the risk of second cancers.
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Introduction
Linear Accelerator (Linac) arc based stereotactic radiotherapy
is used with increasing frequency to treat brain tumors. This
approach can be used for single (stereotactic radiosurgery
(SRS)), or fractionated treatments (stereotactic radiotherapy
(SRT)), It is typically carried out with circular collimators
which are optimal for small, spherical targets. Treatment
planning using fixed non-coplanar beams or intensi-
ty-modulated beams may enhance the ability to conform to
irregularly shaped and/or large tumors, especially when
combined with stereotactic localization.1 Despite the highly
localized doses that may be delivered via stereotactic radia-
tion, a small dose is nonetheless delivered to out of field re-
gion, which may cause detriment to the patient. Peripheral
dose (PD) raises questions of treatment optimization, partic-
ularly in cases where patients have a long life expectancy in
which secondary effects may become clinically manifest,
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especially in the treatment of pediatric patients or in those
with a non-malignant primary.2
Peripheral dose results from leakage through the collima-
tor/source head, from scattered radiation within the patient
and from surrounding materials. Knowledge of peripheral
dose is essential in evaluation of radiation protection impact
to patient during the treatment. However, determination of
the peripheral doses, such as the dose to critical organs of
patients has been the subject of extensive investigation. The
values were derived from measurements of contributions to
the PD, i.e., from radiation scattered in the patient, leakage
radiation and radiation scattered from the collimator/source.
The choices of treatment machine and specific peripheral
dose data are quite useful in risk reduction and, perhaps, in
the selection of optimal treatment technique.3
One goal of radiosurgery is to design a treatment plan in
which the prescription isodose line covers the target with a
minimal excess volume and a sharp dose. Several different
conformity indices have been reported to describe the con-
formity of the prescription isodose to the target volume. The
PITV recommended to be determined by the Radiation
Therapy Oncology Group RTOG. The PITV is defined as the
ratio of the prescription isodose volume (PI) to the target
volume (TV). Conformity indices are used to compare com-
peting plans, evaluate treatment technique, and assess clinical
complications by quantifying the dose conformity to a target
volume. Several different indices have been reported to
evaluate the conformity of prescription isodose surface to the
target volume.4
The primary beam and its immediate periphery (in-field), as
well as in regions far from the primary field (out-of field),
Poor knowledge of in-field characteristics may lead to re-
duced treatment efficacy, whether by under-dosage of tar-
geted tumours or over-irradiation of adjacent healthy tissues.
Poor knowledge of out-of-field characteristics may result in
adverse health consequences, such as radiation-induced car-
cinogenesis. The increasing success of radiotherapy is result-
ing in longer patient lifetimes, and as such there is greater
time in which (typically latent) radiation-induced cancers
may become manifest. Peripheral dose raises questions of
treatment optimization, particularly in cases where patients
have a long life expectancy in which secondary effects may
become manifest, such as in the treatment of pediatric pa-
tients or those with a non-malignant primary.5
The main components of peripheral dose are leakage from
LINAC head, scattered radiation from collimators and leaves,
and scattered radiation within the patient. The first two
contributors depend on the technique employed, as well as
the device and its layout. Scattered radiation within the pa-
tient, in turn, depends on radiation energy, the distance from
the edges of the field, and, to a lesser extent, the field size.6
Secondary tumour induction may seem a relatively signifi-
cant problem, since the patient has to survive the primary
tumour long enough for a secondary one to becomeobvious.7
A goal of stereotactic radiosurgery (SRS) is to achieve opti-
mal dose-volume conformity (i.e., to limit the prescription
dose to a volume closely coincident with the target volume),
thus excluding normal tissue (NT) from the high-dose re-
gion. It has been shown that complications from SRS are
related to the volume of NT receiving a minimal dose. Con-
versely, it is important to maintain a high degree of coverage
of the target volume (TV) by the prescription dose, because a
reduction in dose to spare normal structures has been shown
to lead to an unacceptable rate of tumor recurrence.8 A
knowledge of the doses to be deposited outside the treatment
volume beforehand may allow a risk estimate of detrimental
effects and, if possible, precautions to minimize the probabil-
ity of developing them. To this end, several studies have
been carried out with the aim of identifying different com-
ponents of peripheral dose and the possible actions that can




Ten patients with different tumor sizes, shapes and localiza-
tions were selected for this study. All selected patients were
treated with stereotactic radiosurgery (SRS) at Children's
Cancer Hospital, Egypt, (CCHE). The target volumes ranged
from 6 to 16 CC. Three plans were performed created for
each patient. These treatment plans were generated using
three different techniques: Arcs, noncoplanar fixed fields and
intensity modulation techniques. Each plan will individually
be optimized according to the selected treatment techniques.
Beam angles were chosen to minimize doses to the critical
structures and to achieve high dose fall-off around the target
at the same time. A Linear Accelerator 6 MV arc based ste-
reotactic (Siemens ONCORTM Impression Linear Accelera-
tor). Attached to Circular Collimators (Radionic, Integra
Radionics, Burlington, MA) have maximum cone of 40 mm
diameter or Siemens Moduleaf Collimator (mMLC; leaf pro-
jection at the isocenter: 4 mm) has weight 39.7 Kg with
Cosmic 2.3 software.
Ten patients with brain lesions who were previously treated
with Stereotaxy radiosurgery (SRS) using the cones (Arcs
technique), were re-planned both non-coplanar 3D Confor-
mal fixed fields (3DCRT) and non-coplanar intensity modu-
lated radiotherapy fixed fields (IMRT) with the same ar-
rangement and orientation of the fields as the Arcs technique.
The selected cases were chosen to represent varying tumor
shape, size, location and proximity to critical organs. The
mean planning target volume (PTV) of the selected cases was
10.9 ± 3.7 cm3 (ranged 6 cm3- 16 cm3).
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To maintain the accuracy and precision desired in SRS two
basic conditions were used: immobilization of the patient
during the treatment and the exact determination of tumor
position. These two conditions were promptly achieved using
an invasive frame and localizer.
A physician screws the stereotactic frame on the patient's
head. Using of frame solves two problems: 1) minimize the
chance of head movement with respect to frame (immobili-
zation) and 2) it sets up an external frame with respect to
which co-ordinates of the tumor could be defined (localiza-
tion). To determine the co-ordinate of the tumor a localiza-
tion frame with N-shape fiducial rods is attached to the head
frame before the patient undergoes imaging.
Diagnostic imaging modalities used in stereotactic radiosur-
gery are 1) computed tomography (CT) and 2) Magnetic
Resonance Imaging (MRI).
By using an advanced software (radionics software), it is
possible to superimpose geometrically CT and MRI images to
use the information of both image modalities. This process is
called "fusion". Once the images are fused, different viewing
tools allow the planner to view the images superimposed on
top of each other. The goal of SRS planning is to deliver the
maximum dose to the tumor and the minimum dose to the
surrounding healthy tissues. Each patient was scanned by CT
while fixed in the stereotactic head frame and localizer. Scan
was made with 2-mm slice thickness. All patients also had an
MRI scan of the brain.
Treatment Planning
Once the imaging is complete, data is transferred to a Treat-
ment Planning System (TPS). In the TPS all the CT image
slices are localized. The fiducials of the localizer box are
found to determine the co-ordinate system used for planning,
then image fusion between CT and MRI images is performed
and the physician contours the target and the organ at risks
(OAR) structures on the fused image slices.
Once the target and the OARs are contoured, a radiosurgery
plan may be developed. Three plans will be created for each
patient. Three treatment plans have been generated using
three techniques: ARCs, non-coplanar (3DCRT) fixed fields
and non-coplanar (IMRT), the three plans have the same
orientation and arrangement of the fields. First ARC plan was
made, the OARs were avoided as much as possible by select-
ing the optimal table positions, arc angles and the most fitted
cone size, then Arc plan was converted into 3DCRT and
IMRT fixed fields plans. Beam shaping for 3DCRT and IMRT
were carried out using Siemens Moduleaf of 2.5 mm width.
Each plan has been individually optimized according to the
treatment techniques selected. All plan parameters were
re-chosen to minimize doses to the critical structures and to
achieve high dose fall-off around the target at the same time.
All treatment plans were made on Radionics treatment plan-
ning system X-Knife radionics by using primary + scatter
algorithm. The adaptation of the dose-volume constraints on
an individual basis enabled better avoidance of critical organs.
The primary objective for each plan was to 95% of the Plan-
ning target volume (PTV) covered by 95% of the prescribed
dose while minimizing the dose to OARs. All plans were
generated using a single isocenter. A dose of 12 Gy in a single
fraction was prescribed and normalized to the isocenter.
Plan Quality
Dose Volume Histogram
All plans were optimized such that 95% of the volume of PTV
received 95% of the prescribed dose of 12 Gy.
Conformity Indices
One goal of radiosurgery is to design a treatment plan in
which the prescription isodose line covers the target with a
minimal excess volume and a sharp dose fall-off outside the
target volume. However, planning or ‘‘mapping’’ the pre-
scription isodose to a specific target shape can be a challeng-
ing task. Several different conformity indices have been re-
ported to describe the conformity of the prescription isodose
to the target volume.
The PITV recommended in the Radiation Therapy Oncology
Group (RTOG) radiosurgery guidelines is probably the most
frequently quoted.8 The PITV Equation 1 is defined as the
ratio of the prescription isodose volume (RI) to the target
volume (TV). The RTOG guidelines define a ratio of 1.0-2.0 as
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The PITV index presents a major drawback: It can never take
into account the degree of spatial intersection of two volumes
or their shapes. In extreme cases, it may be equal to 1 while
these two volumes are situated away from each other and
present.
Another Index was used in this study called Conformation
Number (CN) 8, A conformation number to quantify the
degree of conformality in brachytherapy and external beam
irradiation was a good illustration example. Calculation of
this CN simultaneously takes into account irradiation of the
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OAR: Organ at Risk,
TVRI: Target volume covered by the reference isodose,
VRI: Volume of the reference isodose.
FIG. 1: Shows the various volumes required to calculate the PITV
and CN.
Integral Dose
The integral dose is reported as the sum of all dose voxel times
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Where, N: the number of voxels,
Dmean: The mean dose to the body contour,
mvoxel: The mass of a voxel.
Although for a proper evaluation of integral dose different
density values should be considered for different structures,
for the sake of simplicity a constant density ρ = 1 g/cm3 was
assumed for all structures.
Volume receiving 2 Gy and 5 Gy
Some models of radiation carcinogenesis suggest that the
dose-response relationship is linear up until a dose 6 Gy,
where it then reaches plateau.11 The volume receiving 2 Gy
and 5 Gy were reported in this study for each treatment plan.
Estimation of treatment delivery time
Recorded of the monitor units (Mu) of each treatment plan
gave us a reasonable data to estimate the treatment delivery
time.
Statistics
For the statistical analysis we used SPSS, version 20 (SPSS
Inc., Chicago, IL). To analyze the differences between the
Arcs, 3DCRT and IMRT plans, ANOVA test was used for the
three techniques. The level of statistical significance was
considered p < 0.05 for all calculation; therefore, a 95% con-
fidence interval was applied.
Results
Dose Volume Histogram
The dose volume evaluation for the target with the three
different techniques was performed. The data for all patients
is presented in Table 4.1. All Plans were optimized such that
95% of the volume of the PTV received 95% of the prescribed
dose. Dose volume criteria are illustrated in Figure 4.1.
Where the minimum dose is reported as the dose to the
99.5% of the PTV and the maximum dose is reported as the
dose to 0.5% of the PTV.
TABLE 1: Listed the minimum, maximum, dose homogeneity and














Arcs 1112.3 1217.2 104 1184.1
IMRT 1122.4 1202.7 80 1165.3
Conformal 1110 1244.2 134.2 1203.3
Patient 2(7 CC)
Arcs 1107.8 1287.7 179.8 1204.6
IMRT 1105.9 1218.7 112.8 1166.4
Conformal 1123.5 1331.6 208 1242.9
Patient 3(7.12 CC)
Arcs 1116 1214 98 1178
IMRT 1130 1218 88 1182
Conformal 1108 1242 134 1196
Patient 4(8.47 CC)
Arcs 1109.5 1239.3 129.8 1186.4
IMRT 1120.3 1218.8 98.5 1173.9
Conformal 1103.6 1253.7 150.1 1190.2
Patient 5(10.26 CC)
Arcs 1108.1 1279.3 171.2 1194.6
IMRT 1109.8 1216.5 106.7 1181
Conformal 1101.3 1294.7 193.4 1214.7
Patient 6(11.88 CC)
Arcs 1128.4 1222 93.5 1184.3
IMRT 1130.2 1216.3 86.1 1176
Conformal 1120 1280 140 1207.3
Patient 7(12.12 CC)
Arcs 1112.8 1263.3 150 1182.7
IMRT 1116 1240 124 1178
Conformal 1109.4 1268.7 159.3 1198
Patient 8(13.12 CC)
Arcs 1084.9 1221 136 1176.6
IMRT 1112.5 1208.9 96.5 1172.6
Conformal 1075.4 1229.9 154.5 1183.9
Patient 9(14.62 CC)
Arcs 1121 1279 158 1233
IMRT 1125 1261 136 1196.8
Conformal 1105 1288 182.4 1225.5
Patient10(15.77 CC)
Arcs 1160 1287.9 127.7 1219.2
IMRT 1109.9 1208.2 98.3 1175.9
Conformal 1149.4 1297.3 147.9 1261
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FIG. 2: Dose volume histogram criteria.
Conformity Indices
Table 2 summarizes the PITV conformity index (C.I) and the conformal number between the three different stereotactic tech-
niques.
TABLE 2: The PITV and Conformation Number (CN) for the competing plans.
The chart bars (Figure 3 and Figure 4) represent the PITV
conformity index and the Conformal Number, respectively.
FIG. 3: PITV conformity index for the three different Stereotactic
Techniques.
FIG. 4: Conformal Number for the three different Stereotactic Tech-
niques
Arcs IMRT Conformal
PITV CN PITV CN PITV CN
Patient 1(6 CC) 1.5 0.6 1.3 0.81 1.5 0.6
Patient 2(7 CC) 1.2 0.77 1.1 0.88 1.3 0.69
Patient 3(7.12 CC) 1.4 0.65 1.3 0.77 1.4 0.65
Patient 4(8.47 CC) 1.3 0.73 1.1 0.86 1.3 0.68
Patient 5(10.26 CC) 1.4 0.68 1.2 0.79 1.5 0.68
Patient 6(11.88 CC) 1.3 0.7 1.1 0.88 1.5 0.61
Patient 7(12.12 CC) 1.6 0.69 1.2 0.77 1.6 0.69
Patient 8(13.12 CC) 1.4 0.73 1.1 0.89 1.4 0.73
Patient 9(14.62 CC) 1.5 0.64 1.3 0.74 1.5 0.64
Patien10(15.77 CC) 1.2 0.72 1.1 0.87 1.4 0.64
Mean±SD(10.6±3.4 CC) 1.4±0.13 0.7±0.05 1.2±0.09 0.83±0.05 1.4±0.09 0.67±0.04
PITV comparisons CN comparisons
P Value for comparison between three groups
(ANOVA): < 0.01
Pairwise comparison:
IMRT vs. Arcs: < 0.003
IMRT vs. Conformal: < 0.01
Arcs vs. Conformal: 0.598
P Value for comparison between three groups
(ANOVA): < 0.01
Pairwise comparison:
IMRT vs. Arcs: < 0.01
IMRT vs. Conformal: < 0.01
Arcs vs. Conformal: 0.405
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Integral Dose
The mean integral dose using the 3 different techniques for
all studied patients were: 2.44 ± 0.36, 2.31 ± 0.37 and 2.6 ±
0.37 in the Arcs, IMRT and 3DCRT techniques respectively.
The differences were not statistically significant (p=0.326)
(Table 3 and Figure 5).




Patient 1(6 CC) 1.89 1.8 1.98
Patient 2(7 CC) 2.16 1.99 2.31
Patient 3(7.12 CC) 2.19 2.1 2.34
Patient 4(8.47 CC) 2.24 2.13 2.4
Patient 5(10.26 CC) 2.33 2.18 2.47
Patient 6(11.88 CC) 2.4 2.2 2.5
Patient 7(12.12 CC) 2.53 2.42 2.62
Patient 8(13.12 CC) 2.62 2.51 2.77
Patient 9(14.62 CC) 2.89 2.8 2.93





The Chart bars Figure 5 represents the integral dose in joule.
FIG. 5: The Integral dose for the three different techniques.
The integral dose is defined as (the energy deposited in the
unit mass of the body). In the present work the integral dose
was calculated to be equal of the mean dose in Gy for the all
body and the mass of the body in kilograms (kg). For sim-
plicity, the mass of the body was taken as the product of its
volume and a tissue density of 1 g/cm3. Based on the mean-
ing the integral dose a specific approach has been introduced
that a isodose line in Gy for 1 kg of the body could be repre-




FIG. 6: The integral dose in axial, sagittal and coronal views of 7.12





FIG. 7: The integral dose in axial, sagittal and coronal views of 13.12
CC for three different techniques (a) Arcs, (b) IMRT, and (c)3DCRT.
Volume receiving 2 Gy and 5 Gy
The volumes that received 2 Gy and 5 Gy have been calcu-
lated for all patients where the body contour of each patient
has been delineated and became represented in the DVH as
shown in Figure 8.
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FIG. 8: Derivation of 2Gy and 5Gy by using the DVH.
TABLE 4: Summarizes the volumes in cm3 that receive 2Gy (V2) and 5Gy (V5) for the three different stereotactic techniques.
Arcs IMRT Conformal
V2 V5 V2 V5 V2 V5
Patient 1(6 CC) 180 45.8 187 42.4 221 58
Patient 2(7 CC) 162 49 180 47 282 52.6
Patient 3(7.12 CC) 221 54.17 222 53.15 234 54.1
Patient 4(8.47 CC) 225 61.2 239 55.7 248 64.3
Patient5(10.2 CC) 263 67.1 271 63 294 72.7
Patient6(11.88CC) 272 70 312 68 358 84
Patient7(12.12CC) 361 74.3 402 72.3 450 90
Patient8(13.1 CC) 326 77.5 472 76 504 107
Patient9(14.6 CC) 354 90.9 418 84.8 468 121
Patient 10(15.7 CC) 246 88.7 407 88 467 133
Mean±SD(10.6±3.4CC 261±68.7 67.9±15.5 311±106 65±15.5 352.6±110.3 83.7±28.7
P Value (ANOVA)  for comparison between the three competing techniques regarding V2 : 0.126
P Value (ANOVA)  for comparison between the three competing techniques regarding V5 : 0.118
Figure 8 represents the volume of the patient body that receives (a) 2 Gy and (b) 5 Gy.
FIG. 8: (a) Volume of the Patient body that receive 2 Gy.
FIG. 8: (b) Volume of the Patient body that receive 5 Gy
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TABLE 5: Summarizes the Monitor Units (MUs) required for each techniques.
MUs
Arcs IMRT Conformal
Patient 1(6 CC) 1610 3235 1713
Patient 2(7 CC) 1618 3288 1742
Patient 3(7.12 CC) 1543 3341 1784
Patient 4(8.47 CC) 1588 3373 1721
Patient 5(10.26 CC) 1609 3390 1743
Patient 6(11.88 CC) 1596 3630 1677
Patient 7(12.12 CC) 1699 3719 1709
Patient 8(13.12 CC) 1715 3867 1819
Patient 9(14.62 CC) 1766 3865 1762
Patient 10(15.77 CC) 1794 3887 1829
Mean ±SD(10.6±3.4 CC) 1654±84 3560±262 1750±69
P Value (ANOVA) for comparison between the three competing techniques: < 0.01
Pairwise comparison:
IMRT vs. Arcs: < 0.01
IMRT vs. 3DCRT: < 0.01
Arcs vs.3DCRT: 0.21
Estimation of treatment delivery time
Recorded of the monitor units (Mu) of each treatment plan
gave us a reasonable data to estimate the treatment delivery
time.
The results show that Arcs technique has the lowest volume
of the body that received 2 Gy, IMRT is the next followed by
3DCRT and IMRT technique has the lowest volume of the
body that received 5 Gy, Arcs technique is the next followed
by 3DCRT. The differences were not statistically significant
p = 0.126 for V2 and p = 0.118 for V5, but these differences
might be clinically significant that need more clinical discus-
sion and investigation.
It is clear that the IMRT plan delivery time almost has two
folded more than the two others techniques, and the arc the
technique has the lowest estimated time compared to both
IMRT and Conformal techniques. The differences were sta-
tistically significant (P < 0.01). All techniques have the same
pre-treatment and quality assurance procedures time so the
differences in the treatment delivery time among the com-
peting three stereotactic techniques results in the differ
MUs.
Discussion
The goal of SRS planning is to deliver the maximum dose to
the tumor and the minimum dose to the surrounding healthy
tissues. In this study 3 plans were generated Arcs,
non-coplanar 3DCRT fixed field and non-coplanar IMRT.
First Arc plan was made, Arc plan was made, optimized
where the OARs were avoided as much as possible by se-
lecting the optimal table positions, arc angles and the fitted
cone size, then arc plan was converted into 3DCRT and IMRT
with interval 45oto have the same orientation and arrange-
ment as the arc plan. To facilitate direct comparison between
the competing techniques, the primary planning object was to
cover 95% of the volume of PTV by 95% of the prescribed
dose (1200 cGy).
In this study, the minimum dose for PTV was 93% ± 1.5%,
93.2% ± 0.7% and 92.5% ± 1.6, the maximum dose was 104.3 ±
2.6, 101.7 ± 1.4 and 106.1 ± 2.6, the dose inhomogeneity (the
difference between the max and min dose) was 11.2% ± 2.5%,
8.6% ± 1.5% and 13% ± 2.1% for Arcs, IMRT and 3DCRT
respectively (Table 1).
Conformity has been described using both the PITV ratio
(Equation 1) and the CN (Equation 2). The PITV was 1.4 ±
0.13, 1.2 ± 0.09 and 1.4 ± 0.09 and the CN was 0.7 ± 0.05, 0.83
± 0.05 and 0.67 ± 0.04 for Arcs, IMRT and 3DCRT respec-
tively. As clear that the IMRT technique shows the highest
dose conformity, Arcs the next homogeneity followed by
3DCRT. The differences were statistically significant among
the three different techniques (P < 0.01) for PITV and CN. For
pairwise comparisons regarding PITV the difference were
significant (P < 0.003) for IMRT vs. Arcs and (P < 0.01) for
IMRT vs. 3DCRT and the pairwise comparisons were not
statistically significant (P = 0.598) for Arcs vs 3DCRT. The
pairwise comparisons regarding CN the difference were sig-
nificant (P < 0.01) for IMRT vs. Arcs and (P < 0.01) for IMRT
vs. 3DCRT and the pairwise comparisons were not statisti-
cally significant (P = 0.405) for Arcs vs. 3DCRT
The PITV recommended in the Radiation Therapy Oncology
Group (RTOG) radiosurgery guidelines is probably the most
frequently quoted. A conformity index equal to 1 corre-
sponds to ideal conformation. A conformity index greater
than 1 indicates that the irradiated volume is greater than
the target volume and includes healthy tissues. If the con-
formity index is less than 1, the target volume is only par-
tially irradiated. According to RTOG guidelines, ranges of
conformity index values have been defined to determine the
Volume 2 • Number 4 • 2014 International Journal of Cancer Therapy and Oncology 9
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quality of conformation, because a value of 1 is rarely ob-
tained. If the conformity index is situated between 1 and 2,
treatment is considered to comply with the treatment plan;
an index between 2 and 2.5, or 0.9 and 1, is considered to be
a minor violation, and an index less than 0.9 or more than
2.5 is considered to be a major violation. However, this index
presents a major drawback.15 It can never take into account
the degree of spatial intersection of two volumes or their
shapes. In extreme cases, it may be equal to 1 while these
two volumes are situated away from each other and present
entirely different shapes Figure 9 and the PITV not taken the
healthy tissue into account.
FIG. 9: Four possibilities for which the PITV ratio is equal to 1 (tar-
get volume, shaded; volume of reference isodose, enclosed in black
dashes) Figure was taken from Feuvret et al.15
To compensate for the defects of The PITV and To improve
treatment evaluation van’t Riet et al.8 proposed The CN
which take into account all volume parameters of the lesion
and healthy tissues. In our study we faced a major problem
in the calculation of the CN because the software does not
support all the parameters required to calculate the CN. This
problem has been overcome manually by calculation of the
VRI from help structure delineated over all the volume of the
body. As example to calculate VRI (assume 95% isodose line
is the reference isodose) represented in Figure 10.a and from
DVH Figure 10.b. The intersection of the help structure with
95% dose represents the VRI as illustrated in Figure 10.
In this study IMRT techniques shows superiority in Dose
Homogeneity, Conformity Index, Conformal Number and
has the lowest integral dose followed by Arcs and 3DCRT
techniques that might be results in defining field shapes by
segments minimize the irradiating volume where the dose
optimization in IMRT don't need to add a margin around the
target volume and the beam boundary margin is being auto-
matically minimized for IMRT inverse the 3DCRT which
need to add 3-4 mm margin around the PTV to achieve the
target coverage criteria this increase the normal tissue irra-
diation and the integral dose, and the disadvantage of Arcs
technique with the circular cones is that cones can't fitted
conformaly some of irregular shapes that result in increasing
the dose outside the PTV Figure 10. The minimizing the
mean field sizes give the IMRT technique the superiority in
the dose fall-off outside the PTV. Table 6 shows the mean
field sizes for the three competing techniques.
As shown in Table 6 the mean of equivalent square field
sizes were 19.26 ± 2.3, 17.62 ± 2.31 and 20.44 ± 2.50 for Arcs,
IMRT and 3DCRT respectively. It is clear that IMRT helped
to reduce the mean equivalent field sizes by 9% and 3DCRT
increase the mean equivalent field sizes by 6% compared to
Arcs technique. The field sizes variation illustrate why IMRT
has the lowest integral dose (2.31 ± 0.37 J) followed by Arcs
(2.44 ± 0.36J) and 3DCRT (2.6 ± 0.37J).
Field shaping by cones has some drawbacks that was specific
for irregular shapes where the selection of the most fitted
cone field size related to the biggest dimensions in the irreg-
ular shape, so we found despite of some targets have differ-
ent sizes but shaping by the same cone field size, this clear in
Table 6 for patient 7, patient 9, Patient 10 have different
field sizes (12.12, 14.62, 15.77 respectively) and the same
mean equivalent square field sizes (Figure 11) this might be
result in the most fitted cone size designed to conform the
longest distance between the points of the circumference of
the target in the 3 dimensions, in contrast for IMRT and
3DCRT has been observed that the mean equivalent field
size proportional with the size of the target as shown in Ta-
ble 6, this result in the mMLC designed to conform the tar-
get as a volume in the 3 dimensions, this deduction give
privilege for using mMLC over using the Arcs technique.
FIG. 10: (a) An example for relative isodose lines for the three different techniques.
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FIG. 10: (b) Extraction the VRI using the DVH of the help structure. Graph illustrates the method of calculation of the VRI.
FIG. 10: An example of field size shaping for the three competing techniques:(a) Arcs,(b) 3DCRT, (c) IMRT techniques.
TABLE 6: Listed the mean of equivalent square field sizes of the three competing techniques for all patients.
The mean of equivalent square field sizes (cm2)
Arcs IMRT Conformal
Patient 1(6 CC) 14.5 14.04 17.12
Patient 2(7 CC) 17.4 15.2 18.16
Patient 3(7.12 CC) 17.4 15.2 18.23
Patient 4(8.47 CC) 18.72 17.06 18.87
Patient 5(10.26 CC) 19.5 17.58 19.8
Patient 6(11.88 CC) 20.04 17.94 20.44
Patient 7(12.12 CC) 21.36 18.3 21.64
Patient 8(13.12 CC) 20.97 19.53 21.74
Patient 9(14.62 CC) 21.36 20.37 23.64
Patien10(15.77 CC) 21.36 21.02 24.8
Mean ±SD(10.6±3.4 CC) 19.26±2.3 17.62±2.31 20.44±2.50
FIG. 11: Beam Eye View (BEV) shows the same cone size (4 cm) for different shape size a) 12.12 cc , b)14.62 cc , c) 15.77 cc.
The volumes in cm3 that receive 2Gy and 5Gy have been
recorded Table 4.4., the results shown that the Arcs tech-
nique has the lowest volume receiving 2 Gy, followed by
IMRT and 3DCRT has the highest, in addition the volume
receiving 5 Gy was the lowest in IMRT followed by Arcs and
3DCRT has the highest. This mean that Arcs technique re-
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duce the dose away the target rather than near the target this
might result in for point sources as LINAC based SRS, the
geometric penumbra is inversely proportional to the source
to diaphragm distance, the geometric penumbra is reduced
which helps increase the dose fall off. In contrast with
mMLC attached to the head of linac, the geometric penum-
bra of mMLC is larger, so cones have dose sharp fall-off more
than the mMLC but the increasing the equivalent field sizes
in Arcs compared to IMRT cause the increasing dose receiv-
ing 5Gy around the target for Arcs technique. Based on these
results, we can deduce that the influence of increasing field
sizes for Arcs more than the influence of increasing of MUs
and leaf leakage for IMRT for the dose near the target(V5)
less for the dose away the target(V2).
Only a few studies comparing Arcs, IMRT, 3DCRT stereo-
tactic techniques have been published. Kubo et al.12 per-
formed a planning study involved 11 patients they found
that for non-spherical targets treatment planning is relative-
ly intuitive with mMLC-based radiosurgery. Moreover, a
lower dose of radiation is delivered to normal tissue with
mMLC-based radiosurgery than arc-based radiosurgery, the
authors conclusion is similar to ours in the general idea.
However we expressed the low doses by V2 and V5 because
some models of radiation carcinogenesis suggest that the
dose-response relationship is linear up to until a dose 6 Gy.
Cardinale et al.13 compared the dose conformity and normal
brain dose characteristics of three different stereotactic
techniques (arcs, non-coplanar fixed fields and intensity
modulated) for various nonspherical target shapes of 3 intra-
cranial test targets. The present study conformed the conclu-
sion that IMRT has the superiority in dose conformity for
hemisphere and irregular targets, but they didn't define what
are the high and low dose as Kuboet al.12where we defined it
to be V2 that more favorable with Arcs technique and V5
that more favorable with IMRT.
The potential of single-fraction IMRT SRS has not yet been
fully released. Ernst-Stecken et al.14 evaluated radiosurgery
intensity-modulated stereotactic radiosurgery (IMRT-SRS)
and dynamic conformal arc (DCA) techniques in small
skull-base tumors. They concluded that RTOG radiosurgery
guidelines were best met by the DCA rather than IMSRS
approach for the treatment of small skull-base lesions. The
IMRT- SRS approach will increase the time for planning,
dose delivery and integral dose to the brain. Furthermore,
the results presented in this study were based on dose calcu-
lations performed in Radionics treatment planning system
X-Knife radionics. Future studies may include the use of
different treatment planning systems and dose calculation
algorithms such as collapsed cone convolution superposition
algorithm16 and Acuros XB algorithm17, and how these algo-
rithms affect the peripheral dose and conformity index.
Conclusion
The conformity index, dose homogeneity and the outfield
dose are important aspects of plan quality, although they do
not always receive clinically attention. Our results have been
showed that the superiority of the IMRT in conformity, dose
homogeneity and the lowest volume that received 5 Gy, Arcs
technique has the superiority in lower treatment delivery
time than IMRT and the lowest volume that received 2 Gy.
The 3DCRT don't present a significant advantage among the
competing techniques. Oncologist should be alert of the pos-
sibility of significantly increasing the secondary cancer risk
particularly for pediatric patients because children have a
greater risk of developing a secondary cancer due to their
tissue's higher radiation sensitivity and their longer survival
times.
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